Back to CVE records
High 7.8Published Dec 2, 2025
CVE-2025-64642NMIS/BioDose V22.02 and previous versions' installation directory paths by default have insecure file permissions, which in certain deployment scenarios can enable users on client workstations to mod…
Updated under an hour ago ()
Does this affect you?
It affects mirion biodose/nmis. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Start free and add your stack
Free account, 1 product
NMIS/BioDose V22.02 and previous versions' installation directory paths by default have insecure file permissions, which in certain deployment scenarios can enable users on client workstations to modify the program executables and libraries.
- CVSS
- 7.8 HIGH (v3.1, NVD)CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-732
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Analyzed
- Record last updated
- Sep 25, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
mirion biodose/nmis mirion:biodose/nmis | before 23.0 | NVD |
References
- https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01third-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.